ArticleAnnals of translational medicine2020

Multikinase inhibitors to treat hepatocellular carcinoma failures to sorafenib-time has come for a better approach.

Saleh A Alqahtani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.